China Pharma Holdings (CPHI) Inventory Average (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Inventory Average came in at $1.6 million in Q1 2026, down 38.01% YoY from $2.5 million in Q1 2025, and down 4.62% on a QoQ basis from $1.6 million in Q4 2025.
China Pharma Holdings (CPHI) Inventory Average (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 16 years of Inventory Average data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Inventory Average fell 38.01% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 38.01% YoY) and the FY2025 annual result came in at $1.9 million, down 36.56% from the prior year.
- Inventory Average declined to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $3.8 million in Q3 2023 to a low of $1.6 million in Q1 2026.
- A 5-year average of $3.0 million and a median of $3.2 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average soared 30.75% — and 2026, when it sank 38.01%.
- Tracing CPHI's Inventory Average over 5 years: stood at $2.9 million in 2022, then jumped by 30.75% to $3.8 million in 2023, then plunged by 37.54% to $2.4 million in 2024, then sank by 31.35% to $1.6 million in 2025, then declined by 4.62% to $1.6 million in 2026.
- The last three Inventory Average figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.84 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 3.21 Mn |
| Jun 30, 2022 | 3.72 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Sep 30, 2021 | 3.03 Mn |
| Jun 30, 2021 | 3.32 Mn |